Home › NDC Lookup › Ingredients › Ciprofloxacin Hydrochloride › 69367-0385-01
⚪image loading
(from DailyMed)

Ciprofloxacin Hydrochloride 250 mg Tablet, Film Coated, 100-count — NDC 69367-385-01 (Billing 69367-0385-01)

by Westminster Pharmaceuticals, LLC · 100 TABLET, FILM COATED in 1 BOTTLE

This is a package of 100 tablets of Ciprofloxacin Hydrochloride 250 mg Tablet, Film Coated from Westminster Pharmaceuticals, LLC, marketed since May 2024 and currently FDA-listed; retail pharmacies pay about $0.0751 per tablet (NADAC). It is this product's only package size.

NDC 69367-0385-01
🏷️ FDA NDC (as labeled) 69367-385-01 billing pads the product segment with a zero
Rx only Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Oct 8, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 69367-385-01 alone.

Record
FDA NDC Directory package listing · Human prescription drug
Code segments
69367 labeler · 385 product · 01 package
Package marketed since
May 23, 2024
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Billing quantity
100 EA per package
Barcode (UPC-A, from the NDC)
3 6936738501 5
Medicaid fills, this package
1,636 prescriptions in the last four reported quarters
FDA record last changed
Oct 8, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 69367-385-01
Product NDC 69367-385
11-digit billing NDC 69367038501
NCPDP billing unit EA — each (per item)
Application # ANDA076593
SPL Set ID 6848cadf-f18e-4887-9beb-eb0586940694
Established class (EPC) Fluoroquinolone Antibacterial
Mechanism of action Cytochrome P450 1A2 Inhibitors
Chemical class Fluoroquinolones
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2024-05-23
Route ORAL
Dosage form TABLET, FILM COATED
Substance CIPROFLOXACIN HYDROCHLORIDE
TE code (Orange Book) AB · RLD · RS

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GCN Seq No 009509
GCN 47050
HICL code 004124
Ingredient (HICL) Ciprofloxacin Hcl
HIC1 code W
Therapeutic class — broad (HIC1) Anti-Infecting Agents
HIC2 code W1
Therapeutic class — intermediate (HIC2) Antibiotics
HIC3 code W1Q
Therapeutic class — specific (HIC3) Quinolone Antibiotics
AHFS code 08:12.18.00
AHFS class Quinolone Antibiotics
FDB label name CIPROFLOXACIN HCL 250 MG TAB
FDB brand name Ciprofloxacin Hcl
Legend status F — Federal legend — prescription drug or device
Quick answers
  • GSN (GCN sequence number): 009509
  • GCN: 47050
  • HICL (First Databank): 004124
  • AHFS class code: 08:12.18.00
Why two NDCs? The FDA registers this code as 69367-385-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 69367-0385-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name CIPROFLOXACIN HCL 250 MG TAB Ingredient Ciprofloxacin Hcl
📖 What it is MedlinePlus · NLM

Ciprofloxacin is used to treat or prevent certain infections caused by bacteria. Ciprofloxacin is also used to treat or prevent plague (a serious infection that may be spread on purpose as part of a bioterror attack) and inhalation anthrax (a serious infection that may be spread by anthrax germs in the air on purpose as part of a bioterror attack). Ciprofloxacin is in a class of antibiotics called fluoroquinolones. It works by killing bacteria that cause infections. Antibiotics such as ciprofloxacin will not work for colds, flu, or other viral infections. Using antibiotics when they are not n...

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It treats bacterial infections such as urinary tract, respiratory, skin, bone and abdominal infections, depending on the form. Eye and ear versions treat eye and ear infections. It...
  • Swallow them as prescribed, usually every 12 hours, and finish the full course unless your doctor says otherwise. Keep them 2 hours before or 6 hours after antacids, multivitamins,...
  • How should I take my ciprofloxacin tablets?
  • The most common ones are nausea, diarrhea, vomiting, rash and abnormal liver tests. Most are mild, but tell your doctor if they bother you.
📖 Read our full Ciprofloxacin guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
11
Nutrient depletion considerations

Ciprofloxacin may be associated with lower levels of 11 nutrients — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Ciprofloxacin nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.075 $7.51 / 100 tablets
Medicaid paysCMS SDUD · 12 mo $0.6635 $66.35 / 100 tablets
Medicare drug plans payPart D · Q2 2026 $0.2764 $27.64 / 100 tablets
NADAC price history (per ea) — tap or hover for the price & month
Dec 2025 Mar 2026 Jun 2026 Sep 2026 $0.089 $0.075
▼ Down 16% over the last 10 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
69367-0385-01 You're viewing this Main listing 100 TABLET, FILM COATED in 1 BOTTLE 2024-05-23 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Ciprofloxacin 250 mg 43547-0688-10 Solco 100 tablets $0.075 AB Availability likely —
Ciprofloxacin 250 mg 59651-0866-01 Aurobindo 100 tablets $0.075 AB Availability likely —
Ciprofloxacin Hydrochloride 250 mg 59651-0976-01 Aurobindo 100 tablets $0.075 — Availability likely —
Ciprofloxacin 250 mg 61442-0222-01 Carlsbad 100 tablets $0.075 AB Availability likely —
Ciprofloxacin 250 mg 62135-0308-01 Chartwell 100 tablets $0.075 AB Availability likely —
Ciprofloxacin 250 mg 65862-0076-01 Aurobindo 100 tablets $0.075 AB Availability likely —
Ciprofloxacin Hydrochloride 250 mgthis 69367-0385-01 Westminster 100 tablets $0.075 AB Availability likely —
Ciprofloxacin 250 mg 00143-9927-01 Hikma 100 tablets $0.088 — Availability likely +17%
Ciprofloxacin 250 mg 58657-0675-01 Method 100 tablets $0.104 AB FDA listed +38%
ciprofloxacin 250 mg 16571-0411-05 Rising 50 tablets — AB FDA listed —
ciprofloxacin 250 mg 43063-0410-06 PD-Rx 6 tablets — AB FDA listed —
Ciprofloxacin 250 mg 50090-4600-00 A-S 6 tablets — AB FDA listed —
Ciprofloxacin 250 mg 50090-7297-00 A-S 6 tablets — AB FDA listed —
Ciprofloxacin 250 mg 50090-7581-00 A-S 20 tablets — AB FDA listed —
Cipro 250 mg 50419-0758-01 Bayer 100 tablets — AB FDA listed —
Ciprofloxacin 250 mg 51407-0775-01 Golden 100 tablets — AB FDA listed —
Ciprofloxacin 250 mg 51655-0086-20 Northwind 20 tablets — — FDA listed —
ciprofloxacin 250 mg 54348-0662-06 PharmPak, 6 tablets — AB FDA listed —
Ciprofloxacin 250 mg 60760-0690-10 St. 10 tablets — AB FDA listed —
ciprofloxacin 250 mg 63187-0142-06 Proficient 6 tablets — AB FDA listed —
Ciprofloxacin 250 mg 67046-1460-03 Coupler 30 tablets — AB FDA listed —
Ciprofloxacin 250 mg 67296-2169-01 Redpharm 10 tablets — AB FDA listed —
Ciprofloxacin 250 mg 68071-2383-01 NuCare 10 tablets — AB FDA listed —
Ciprofloxacin 250 mg 68071-3693-06 NuCare 6 tablets — AB FDA listed —
Ciprofloxacin 250 mg 68071-3699-01 NuCare 10 tablets — AB FDA listed —
Ciprofloxacin 250 mg 68071-3901-01 NuCare 100 tablets — AB FDA listed —
ciprofloxacin 250 mg 68071-4260-02 NuCare 21 tablets — AB FDA listed —
Ciprofloxacin 250 mg 68788-8200-01 Preferred 10 tablets — AB FDA listed —
Ciprofloxacin 250 mg 68788-8875-00 Preferred 6 tablets — AB FDA listed —
Ciprofloxacin 250 mg 69117-0008-01 Yiling 100 tablets — AB FDA listed —
Ciprofloxacin 250 mg 69238-2432-01 Amneal 100 tablets — — FDA listed —
Ciprofloxacin 250 mg 70518-2837-02 REMEDYREPACK 30 tablets — — Discontinued —
Ciprofloxacin 250 mg 70518-4133-00 REMEDYREPACK 30 tablets — AB FDA listed —
Ciprofloxacin 250 mg 71205-0636-06 Proficient 6 tablets — AB FDA listed —
Ciprofloxacin 250 mg 71205-0749-05 Proficient 5 tablets — AB FDA listed —
ciprofloxacin 250 mg 71335-0408-00 Bryant 7 tablets — AB FDA listed —
Ciprofloxacin 250 mg 71335-1152-00 Bryant 7 tablets — AB FDA listed —
Ciprofloxacin 250 mg 71335-1867-00 Bryant 7 tablets — — FDA listed —
Ciprofloxacin 250 mg 71335-2097-00 Bryant 7 tablets — AB FDA listed —
Ciprofloxacin 250 mg 71335-2502-00 Bryant 7 tablets — AB FDA listed —
Ciprofloxacin 250 mg 72162-1740-01 Bryant 100 tablets — AB FDA listed —
Ciprofloxacin 250 mg 72189-0304-06 DirectRx 6 tablets — — FDA listed —
Ciprofloxacin 250 mg 72189-0323-06 Direct 6 tablets — AB FDA listed —
Ciprofloxacin 250 mg 72189-0616-06 Direct_Rx 6 tablets — AB FDA listed —
Ciprofloxacin 250 mg 72789-0124-01 PD-Rx 100 tablets — — FDA listed —
Ciprofloxacin 250 mg 72789-0193-06 PD-Rx 6 tablets — — FDA listed —
Ciprofloxacin 250 mg 72789-0519-06 PD-Rx 6 tablets — AB FDA listed —
Ciprofloxacin 250 mg 76420-0214-06 Asclemed 6 tablets — — FDA listed —
Ciprofloxacin 250 mg 76420-0928-01 Asclemed 100 tablets — AB FDA listed —
Ciprofloxacin 250 mg 82804-0256-06 Proficient 6 tablets — AB FDA listed —
Ciprofloxacin 250 mg 82868-0070-14 Northwind 14 tablets — AB FDA listed —
ciprofloxacin 250 mg 82868-0102-14 Northwind 14 tablets — AB FDA listed —
ciprofloxacin 250 mg 85293-0002-01 Umasuto, 100 tablets — AB FDA listed —
Ciprofloxacin 250 mg 85766-0099-01 Sportpharm 100 tablets — AB FDA listed —
Ciprofloxacin 250 mg 50090-2146-00 A-S 6 tablets — AB FDA listed —
Ciprofloxacin 250 mg 85534-0069-00 HAWAII 6 tablets — AB FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2024
On the market since
May 2024
📍
2026
Currently FDA-listed
2 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Ciprofloxacin inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerWestminster Pharmaceuticals, LLC
Application holderAIPING PHARMACEUTICAL INC
FDA applicationANDA076593 (ANDA)
Labeler code69367
First marketedMay 2024
Product typeHuman Prescription Drug
Portfolio186 products on file

More NDCs from Westminster Pharmaceuticals, LLC labeler code 69367

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label
📄 FDA label 19 words ▾

No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
1.6K
Units reimbursed last 4 qtrs
22.4K
Gross reimbursed last 4 qtrs
$14.8K
Avg / prescription
$9.07
Avg / unit
$0.6635
Latest quarter Q1 2026
696Rx
Medicaid pays / ea
$0.6635
gross reimbursed
vs
NADAC / ea
$0.0751
acquisition cost
=
Spread
+$0.5884
+783% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
57% FFS 43% MCO
Fee-for-service · 931 Rx Managed care · 705 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: 385 units · 4.9 per 100k residents WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: no data reported MN Wisconsin: 525 units · 8.9 per 100k residents WI Michigan: 700 units · 7.0 per 100k residents MI New York: 4,323 units · 22.1 per 100k residents NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: 869 units · 20.5 per 100k residents OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: 256 units · 27.9 per 100k residents SD Iowa: no data reported IA Illinois: no data reported IL Indiana: 412 units · 6.0 per 100k residents IN Ohio: 3,505 units · 29.7 per 100k residents OH Pennsylvania: no data reported PA New Jersey: no data reported NJ Massachusetts: no data reported MA California: 6,429 units · 16.5 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: 713 units · 11.5 per 100k residents MO Kentucky: 548 units · 12.1 per 100k residents KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: 222 units · 7.6 per 100k residents KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: 3,475 units · 11.4 per 100k residents TX Florida: no data reported FL
Units reimbursed · per 100k residents
4.929.7
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Ohio 29.7 /100k
2 South Dakota 27.9 /100k
3 New York 22.1 /100k
4 Oregon 20.5 /100k
5 California 16.5 /100k
6 Kentucky 12.1 /100k
7 Missouri 11.5 /100k
8 Texas 11.4 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
← 69367-0383-01 · Westminster 69367-0386-01 · Westminster →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.